Diacutaneous Fibrolysis in Patients with Mild-Moderate Carpal Tunnel Syndrome
Diacutaneous Fibrolysis Intervention in Patients with Mild to Moderate Carpal Tunnel Syndrome May Avoid Severe Cases in Elderly: A Randomized Controlled TrialInt J Environ Res Public Health. 2022 Sep 2;19(17):10983.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Forty-four patients (60 wrists) with mild-moderate carpal tunnel syndrome were randomized to receive 5 sessions of diacutaneous fibrolysis treatment (n=20, 30 wrists) or a sham treatment (n=24, 30 wrists). The primary outcome of interest was the cross-sectional area of the median nerve. Secondary outcomes of interest included numbness on a Visual Analog Scale (VAS), the thickness of the transversa...
Join the Conversation
Please Login or Join to leave comments.